The starting drug (doxorubicin, SN-38, lenalidomide, etoposide, combretastatin, 5-fluorouracil, 6-mercaptopurine, riluzole; 50 mg, 1 equiv. each) was dissolved in dry DMF (5 mL) under a nitrogen atmosphere, and the reaction…
Novel dual action chimera doxorubizen demonstrates superior efficacy to doxorubicin in acute leukemia
